Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Brooks Laboratories Limited
BROOKS | NSE
65.68
INR0.80
1.23%
BROOKS | NSE
Loading StockChartView...
About Brooks Laboratories Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
05/06/2026
Close
65.68
Open
65.00
High
66.50
Low
64.11
Brooks Laboratories Limited manufactures and sells pharmaceuticals in India and internationally. It offers carbapenem drugs; tablets; dry syrup; liquid and dry power injections; and eye/ear drops. The company was incorporated in 2002 and is based in Mumbai India.
View LessBROOKS | NSE
Risk
62.3
Sharpe
-0.82
Luna's Score
51/100
Recommendation
Hold
Luna says (BROOKS | NSE)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
54.3%1 month
62.3%3 months
103.9%6 months
85.0%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
5.74
Debt to equity
0.09
Debt to assets
0.06
Ent. to EBITDA
-23.28
Ent. to rev.
4.85
PEG
-
Other Fundamentals
EBITDA
23.02M
MarketCap
1.75B
MarketCap(USD)
18.46M
Div. yield
-
Op. margin
-0.67
Erngs. growth
-
Rev. growth
14.20
Ret. on equity
-28.08
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
20.65
Range1M
27.34
Range3M
43.40
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.33
Price X volume
2.10M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -23.28 | 24.85 | Cheaper |
| Ent. to Revenue | 4.85 | 11.40 | Cheaper |
| PE Ratio | - | 51.36 | - |
| Price to Book | 5.74 | 6.83 | Par |
| Dividend Yield | - | 0.52 | - |
| Std. Deviation (3M) | 103.88 | 42.17 | Riskier |
| Debt to Equity | 0.09 | 0.35 | Cheaper |
| Debt to Assets | 0.06 | 0.17 | Cheaper |
| Market Cap | 1.75B | 290.82B | Emerging |
